Ubs Asset Management Americas Inc Morphic Holding, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 19,881 shares of MORF stock, worth $677,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,881
Previous 19,881
-0.0%
Holding current value
$677,345
Previous $574,000
21.78%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$160 Million0.42% of portfolio
-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...